The re-emergence of the ER-α and ER-α-regulated genes and the partial loss of ER-β during PCa progression and hormone-refractory disease suggest a bypass of the androgenic cascade for these tumors and the utilization of alternative steroidal pathways [76]. The gene discussed is ESR2; the disease is posterior cortical atrophy.